Impact Factor
4.29
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
6.73
1,579 total citations
h5-index
47
h5 depth signal
Cited share
94.1%
223 of 237
Total citations
1,579
Citation footprint
Metric signal
7.35
External metric anchor
Self-citation
1.8%
28 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
298
China
176
India
147
Italy
102
United Kingdom
97
Citing Fields of Research
Drug Delivery Systems
852
Polymer & Macromolecule Science
194
Nanoparticles
147
Oncology
84
Immunology
60
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,515
Articles tracked across the journal lifetime
Indexed publication set
237
223 cited publications
Last 12 months
130
10.8 publications/month
Open access share
23.8%
31 OA publications in the last year
Leading citing country
United States
298 citing publications
Leading citing field
Drug Delivery Systems
852 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Nov. 2004-
v1n1, Nov. 2004-
Active Coverage
Research Focus & Classification
Indexed Subjects
Drug Delivery Systems
Broad Categories
Drug Therapy
Pharmacology
Drug Delivery Systems
Polymer & Macromolecule Science
Epithelial Barriers
MeSH Descriptors
Drug Delivery Systems
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/17425247.2026.2748749
Open DOI
A pharmacokinetic study comparing a low-dose estrogen contraceptive transdermal system with an oral contraceptive tablet in healthy adult females
1. According to World Health Organization estimates, approximately 1.9 billion women of reproductive age (15–49 years) worldwide require access to contraceptive options, and an estimated 164 millio...
02
DOI 10.1080/17425247.2026.2748106
Open DOI
‘Harmful’ or ‘excipients of concern’? Rethinking terminology and risk in pediatric excipients
03
DOI 10.1080/17425247.2026.2748249
Open DOI
Inhalation therapies in interstitial lung diseases
04
DOI 10.1080/17425247.2026.2748107
Open DOI
Strategies for endoplasmic reticulum-targeted delivery systems: current design principles and trends
05
DOI 10.1080/17425247.2026.2747552
Open DOI
Recent advancements and translational potentials of MOF-based precision strategies for breast cancer therapy
06
DOI 10.1080/17425247.2026.2748109
Open DOI
Nanotechnology meets neurodegeneration: restoring lysosomal function with nanovectors
1. Neurodegenerative diseases (NDs) are a heterogeneous group of disorders characterized by the progressive degeneration of neurons in the central or peripheral nervous system. Under this terminolo...
07
DOI 10.1080/17425247.2026.2727111
Open DOI
Preclinical and clinical evaluation of an ocular nanoemulsion for the treatment of dry eye disease
08
DOI 10.1080/17425247.2026.2696893
Open DOI
Lipid vesicular nanocarriers for the management of atopic dermatitis: a paradigm shift in healing
09
10
DOI 10.1080/17425247.2026.2739504
Open DOI
Cubosome-based skin delivery: from topical to transdermal applications
Bibliographical & Catalog Notes
Description based on: Vol. 2, no. 1 (Jan. 2005); title from cover.
Also issued online.